-
St. Jude announces extensive resource to advance leukemia research
11/14/2018
The Public Resource of Patient-derived and Expanded Leukemias (PROPEL) offers patient-derived xenograft samples free of charge for researchers worldwide.
-
Researchers reveal why Hippo pathway may have an outsized effect on solid tumor
10/30/2018
A surprising mechanism that might explain how the Hippo signaling pathway promotes solid tumor growth.
-
Small risks may have big impact on breast cancer odds of childhood cancer survivors
10/26/2018
Common genetic variations may help find female childhood cancer survivors at increased risk of breast cancer and who are candidates for stepped up screening.
-
Obesity problem starts early phase of therapy in children with acute lymphoblastic leukemia
10/25/2018
Children with ALL gain weight during treatment, and researchers suggest that early interventions should be considered.
-
Collaboration yields possible treatment for rare neurodegenerative disorder
10/23/2018
Read how a discovery in bacteria in the 1980s led to a promising new class of compounds for treatment of PKAN, a progressive neurodegenerative disease.
-
St. Jude investigators present novel pediatric cancer genome sequencing data at ASHG
10/17/2018
Presentations outline data from Genomes for Kids study, proving clinical utility of multi-platform genome sequencing for pediatric precision oncology.
-
Researchers find a ‘critical need’ for whole genome sequencing of young cancer patients
10/11/2018
Including whole-genome sequencing into clinical genomic testing found cancer-driving mutations other sequencing methods failed to identify.
-
St. Jude researchers awarded grant to lead pharmacogenetics implementation efforts
10/04/2018
The funding will support CPIC, which provides guidelines to help clinicians understand how genetic test results should be used to optimize drug therapy.
-
World Health Organization, St. Jude Children’s Research Hospital collaborate against childhood cancer
09/27/2018
New global childhood cancer effort aims to cure at least 60 percent of children with six of the most common kinds of cancer worldwide by 2030.
-
Method identified to reduce risk of brain damage in leukemia survivors
09/24/2018
St. Jude scientists have discovered a link between sepsis during cancer treatment and long-term neurocognitive dysfunction.
-
What can salad dressing tell us about cancer? Think oil and vinegar.
09/20/2018
Evidence suggests liquid phase separation, a process that explains why oil and water separate, may contribute to cancer, including prostate cancer.
-
High-resolution genomic map gives scientists unprecedented view of brain development
09/13/2018
The research will aid basic understanding of brain development, and also help understanding cellular origins of brain disorders caused by errors in development.
-
Discovery of a cancer promoter offers pathway to overcome drug resistance
09/12/2018
Geneticists discovered that mTORC3 aids cancers' resistance to rapamycin and related drugs, offering the promise of new drug therapies to treat cancers.
-
St. Jude researchers solve a central mystery of a baffling high-risk leukemia
09/12/2018
Read the latest on the roots of mixed phenotype acute leukemia (MPAL), including how the findings might affect treatment of patients with the high-risk cancer.
-
CBS Sports HQ To Stream Live Fantasy Football Telethon on Labor Day
08/28/2018
CBS Sports HQ will partner with St. Jude to support Childhood Cancer Awareness Month by streaming a live Fantasy Football Telethon on Labor Day.
-
Immune system prioritizes distinct immune responses in infants with flu
08/28/2018
Flu infections pose a significant risk to infants. Read about the T cells the immune system relies on to repair lung damage in infants infected with influenza.
-
Integrated analysis finds vulnerabilities to target in a high-risk pediatric tumor
08/23/2018
Read about what happened when researchers looked beyond mutations to understand the developmental origins and vulnerabilities of rhabdomyosarcoma.
-
St. Jude achieves consecutive highest rating from National Cancer Institute during Cancer Center renewal grant
08/22/2018
St. Jude is the first and only NCI-designated Comprehensive Cancer Center that is devoted solely to children.
-
2017 FedExCup Champion Justin Thomas and NBC’s THE TONIGHT SHOW host Jimmy Fallon Competed in High-Stakes Golf Competition
08/16/2018
Ahead of the 2018 FedExCup Playoffs, defending FedExCup champion Justin Thomas completed against NBC’s The Tonight Show Starring Jimmy Fallon in a friendly golf game, with FedEx donating $1 million to St. Jude in honor of the winner.
-
Late effects of treatment hinder independence of adult survivors of childhood brain tumors
08/09/2018
St. Jude investigators find that cognitive impairment and physical performance limitations are strong predictors of non-independence in survivors.
-
Financial checkup should be part of health screenings for childhood cancer survivors
08/01/2018
Financial hardship is widespread among childhood cancer survivors, reducing their quality of life and leaving them at risk for depression, other problems.
-
Solution to medical mystery may help some children avoid bone marrow transplantation
07/26/2018
Researchers identify mutations responsible for an inherited bone marrow disorder and evidence some affected patients may regain normal immune function without treatment.
-
St. Jude collaborates to improve knowledge of childhood cancer worldwide
07/18/2018
The partnership with Institute for Health Metrics and Evaluation will provide more accurate estimates of the global burden of cancer among children.
-
Scientists identify a protein complex that shapes the destiny of T cells
07/06/2018
Metabolic activity in immune cells influences the fate of developing T cells, including a protein complex that plays a decisive role.
-
"Substantial portion" of childhood cancer survivors not concerned about their future health
06/25/2018
Surveys from the Childhood Cancer Survivor Study found that a surprisingly high number of survivors showed a lack of concern for their future well-being.
-
Engineered 'starter key' for brain tumor offers new model for drug testing
06/25/2018
Researchers have applied a new way to trigger medulloblastoma in neural cells that will lead to the ability to test a promising class of anti-tumor drugs.
-
St. Jude CEO James Downing ranked No. 5 of Glassdoor’s Top 100 CEOs
06/20/2018
Under Downing’s leadership, St. Jude has increased employee feedback channels and forums, resulting in more innovation and connectivity across the Memphis-based campus.
-
Researchers develop a better method to compare gene expression in single cells
06/19/2018
Check out a new algorithm that is available at no cost to help researchers get the most out of single-cell RNA sequencing technology.
-
St. Jude partners with nation’s top cancer centers to endorse goal of eliminating HPV-related cancers in the United States
06/07/2018
Joint statement empowers parents, young adults and physicians to act to increase vaccination rates and screenings to eliminate HPV-related cancers
-
Rigorous study finds widely used treatment for infection fails young cancer patients
06/05/2018
Study found ethanol-lock therapy failed to prevent new or recurring infections in cancer patients with central venous catheters and led to more complications.
